We are the witnesses of the paradigm shift in healthcare approach that is proceeding slowly but consequently closer to personalized medicine. The idea is to apply treatment that would be very specific for target patient, instead of using similar therapies for various people that may respond in a mark...
Read more
After lingering debates and discussions with stakeholders, the European Medicines Agency has finished a policy on the publication of clinical data regarding medical products for human use. The system that will allow future investigation of clinical trial information is not free from controversies....
Read more
In vitro diagnostics is one of the most rapidly expanding market in the area of global healthcare. As the general medical approach is definitely changing, making prevention and early detection the highest priorities, all branches of diagnostics are undoubtedly of major importance and should be proper...
Read more
Somatic stem cells are found to have an application in regenerative medicine. They are used more often to rebuilt damaged structures of the tissues or whole organs. This is the type of stem cells, that are present in adult human body in comparison to embryonic stem cells. They have the ability to tra...
Read more
Oder 2014 - German Polish biobusiness bridge is dedicated to companies working in a field of Life Science sector. This event is primarily partner meeting which aims to bring together people in a common plane business....
Read more
Umbilical cord blood is considered as a promising source of hematopoietic stem cells and other progenitor cells that can potentially be used for treatment of different disorders. Cord blood is easy to collect and its cells possess certain advantages over those encountered in bone marrow. However, the...
Read more
Central Europe 2020 Programme is aimed to support regional cooperation among nine EU Member States, mainly in the area of innovative technologies based on knowledge. In the interview for cebiotech, Mr Luca Ferrarese, Head of the Central Europe Joint Secretariat, describes the idea of the programme an...
Read more
Burrill LLC is launching “Burrill Life Sciences and Healthcare Incubator”. It will allow entrepreneurs from the biotech and healthcare business to benefit from Steven Burrill’s worldwide experience and network. The Incubator will serve as a counsel, mentoring and network tool....
Read more
EuropaBio, being the European Association for Bioindustries, has nominated five most innovative small and medium enterprises (SMEs) of the European Union, which will eventually compete for a first place on October 8th in Brussels. The annual EuropaBio award is a great opportunity for all companies to...
Read more
A growing number of antibiotic-resistant pathogens is an emerging problem of our time. Hungarian researchers have published a paper in “Nature Communications”, in which they recount how bacteria can adapt to antimicrobial drugs and reveal that in the same time microorganisms become resistant to other...
Read more
One of the most critical global challenges that people will have to face with are future effects of climate change, which have been widely neglected for many years and are sometimes still considered as “not our problem”. Agricultural biotechnology might be an indispensable tool for coping with such c...
Read more
Citizen laboratories, also known as DIY labs, are becoming increasingly popular in the science enthusiasts community. They offer free access to advanced laboratory equipment to people not associated with academia. Such places certainly can harness talent but can they really compete with university-ba...
Read more
For centuries Cannabis has been used as a medical therapy for various diseases. Recent study performed at the University of Debrecon by Hungarian researchers has revealed that cannabidiol that is present in the plant might be used for more effective treatment of acne vulgaris....
Read more
Horizon 2020 programme is the biggest financial instrument created by European Union (EU), which is aimed to support research and innovation development. With almost €80 billion funding that can be invested during years 2014-2020, the programme should help in keeping European economies competitive on...
Read more
So far cattle, pig and chicken were the main sources of collagen. Because of common bovine spongiform encefalopathy (BSE) and the high production costs, the researchers were looking for other sources. Collagen is widely used in cell culture, as certain cells are adhesion-dependant (for example human ...
Read more
Point-of-care testing (POCT) provides rapid diagnostic tests that enable to make medical decisions much faster. The POCT market is one of the fastest-developing fields of laboratory medicine, which is triggered by a general need for simple and cheap technologies. Nevertheless, as it grows, simultaneo...
Read more
European Commission (EC) approved the bevacizumab (Avastin) as a medication in treating recurrent ovarian cancer resistant to chemotherapy containing platinum. Avastin has to be combined with paclitaxel, topotecan, or pegylated liposomal doxorubicin chemotherapy....
Read more
According to the World Health Organization (WHO) the Ebola outbreak in West Africa is to date the worst one with more than 1,200 people dead because of the infection. Although the virus has been discovered approximately 40 years ago it is still extremely hard to manage as no effective cure or vaccine...
Read more
Common cat parasite which is harmful and sometimes deadly to people can be transformed into anticancer vaccine. Tumors disturbed natural immune response in order to be safe against natural forces defense of the body. While T. gondii is presence in cells, they started to produce toxic lymphocytes T an...
Read more
In 2012 total cost of pharmaceuticals with marketing authorization was estimated on 13.2 billion NOK, but the patients has to payed for those about 20 billion NOK. It is extremely difficult to evaluate general sale of non-prescription medicines (OTC) in Norway. Those pharmaceuticals are distributed n...
Read more